Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome
Emmanuel Montassier,Gabriel A. Al-Ghalith,Camille Mathé,Quentin Le Bastard,Venceslas Douillard,Abel Garnier,Rémi Guimon,Bastien Raimondeau,Yann Touchefeu,Emilie Duchalais,Nicolas Vince,Sophie Limou,Pierre-Antoine Gourraud,David A. Laplaud,Arnaud B. Nicot,Jean-Paul Soulillou,Laureline Berthelot
DOI: https://doi.org/10.3389/fimmu.2019.03000
IF: 7.3
2020-01-13
Frontiers in Immunology
Abstract:Because of a loss-of-function mutation in the GGTA1 gene, humans are unable to synthetize α1,3-Galactose (Gal) decorated glycans and develop high levels of circulating anti-α1,3-Galactose antibodies (anti-Gal Abs). Anti-Gal Abs have been identified as a major obstacle of organ xenotransplantation and play a role in several host-pathogen relationships including potential susceptibility to infection. Anti-Gal Abs are supposed to stem from immunization against the gut microbiota, an assumption derived from the observation that some pathogens display α1,3-Gal and that antibiotic treatment decreases the level of anti-Gal. However, there is little information to date concerning the microorganisms producing α1,3-Gal in the human gut microbiome. Here, available α1,3-Galactosyltransferase (GT) gene sequences from gut bacteria were selectively quantified for the first time in the gut microbiome shotgun sequences of 163 adult individuals from three published population-based metagenomics analyses. We showed that most of the gut microbiome of adult individuals contained a small set of bacteria bearing α1,3-GT genes. These bacteria belong mainly to the Enterobacteriaceae family, including <i>Escherichia coli</i>, but also to Pasteurellaceae genera, <i>Haemophilus influenza</i> and <i>Lactobacillus</i> species. α1,3-Gal antigens and α1,3-GT activity were detected in healthy stools of individuals exhibiting α1,3-GT bacterial gene sequences in their shotgun data.
immunology